XML 31 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Cash and due from banks (restricted cash of $266 and $5,808) $ 555,919,000 $ 327,313,000
Interest bearing cash and temporary investments (restricted cash of $1,083 and $4,688) 3,079,266,000 967,330,000
Total cash and cash equivalents 3,635,185,000 1,294,643,000
Investment securities    
Equity and other, at fair value 76,532,000 72,959,000
Available for sale, at fair value 9,249,600,000 3,196,166,000
Held to maturity 2,432,000 2,476,000
Loans held for sale, at fair value 49,338,000 71,647,000
Loans and leases (at fair value: $294,012 and $285,581) 37,091,280,000 26,155,981,000
Allowance for credit losses on loans and leases (417,464,000) (301,135,000)
Net loans and leases 36,673,816,000 25,854,846,000
Restricted equity securities 246,525,000 47,144,000
Premises and equipment, net 375,190,000 176,016,000
Operating lease right-of-use assets 127,296,000 78,598,000
Goodwill 1,030,142,000 0
Other intangible assets, net 702,315,000 4,745,000
Residential mortgage servicing rights, at fair value 178,800,000 185,017,000
Bank owned life insurance 641,922,000 331,759,000
Deferred tax asset, net 351,229,000 132,823,000
Other assets 653,904,000 399,800,000
Total assets 53,994,226,000 31,848,639,000
Deposits    
Non-interest bearing 17,215,781,000 10,288,849,000
Interest bearing 24,370,566,000 16,776,763,000
Total deposits 41,586,347,000 27,065,612,000
Securities sold under agreements to repurchase 271,047,000 308,769,000
Borrowings 5,950,000,000 906,175,000
Junior subordinated debentures, at fair value 297,721,000 323,639,000
Junior and other subordinated debentures, at amortized cost 108,066,000 87,813,000
Operating lease liabilities 140,648,000 91,694,000
Other liabilities 755,674,000 585,111,000
Total liabilities 49,109,503,000 29,368,813,000
COMMITMENTS AND CONTINGENCIES (Note 9)
SHAREHOLDERS' EQUITY    
Preferred Stock, no par value, shares authorized: 2,000,000, issued and outstanding: 0 0 0
Common stock, no par value, shares authorized: 520,000,000 in 2023 and 238,320,000(1) in 2022; issued and outstanding: 208,429,244 in 2023 and 129,320,962(1) in 2022 5,788,553,000 3,450,493,000
Accumulated deficit (603,696,000) (543,803,000)
Accumulated other comprehensive loss (300,134,000) (426,864,000)
Total shareholders' equity 4,884,723,000 2,479,826,000
Total liabilities and shareholders' equity $ 53,994,226,000 $ 31,848,639,000